Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Drug-induced atrial fibrillation.

van der Hooft CS, Heeringa J, van Herpen G, Kors JA, Kingma JH, Stricker BH.

J Am Coll Cardiol. 2004 Dec 7;44(11):2117-24. Review.

2.

Drug-induced heart failure.

Feenstra J, Grobbee DE, Remme WJ, Stricker BH.

J Am Coll Cardiol. 1999 Apr;33(5):1152-62. Review.

3.

Novel approaches for pharmacological management of atrial fibrillation.

Ehrlich JR, Nattel S.

Drugs. 2009;69(7):757-74. doi: 10.2165/00003495-200969070-00001. Review.

PMID:
19441867
4.

Drug-induced atrial fibrillation.

Tamargo J, Caballero R, Delpón E.

Expert Opin Drug Saf. 2012 Jul;11(4):615-34. doi: 10.1517/14740338.2012.698609. Review.

PMID:
22724662
5.

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.

Savelieva I, Camm J.

Europace. 2008 Jun;10(6):647-65. doi: 10.1093/europace/eun130. Review.

PMID:
18515286
6.

Introducing a new entity: chemotherapy-induced arrhythmia.

Guglin M, Aljayeh M, Saiyad S, Ali R, Curtis AB.

Europace. 2009 Dec;11(12):1579-86. doi: 10.1093/europace/eup300. Epub 2009 Oct 3. Review.

PMID:
19801562
7.

Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.

Elahi MM, Flatman S, Matata BM.

Eur J Cardiovasc Prev Rehabil. 2008 Dec;15(6):735-41. doi: 10.1097/HJR.0b013e328317f38a. Review.

PMID:
19020458
8.

Medical management of atrial fibrillation.

Hersi A, Wyse DG.

Curr Cardiol Rep. 2006 Sep;8(5):323-9. Review.

PMID:
16956446
9.

Risk of atrial fibrillation with high-dose corticosteroids.

Chiappini B, El Khoury G.

Expert Opin Drug Saf. 2006 Nov;5(6):811-4. Review.

PMID:
17044807
10.

Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.

de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA.

Arch Intern Med. 2005 Feb 14;165(3):258-62. Review.

PMID:
15710787
11.

Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.

Talajic M, Roy D.

Can J Cardiol. 2005 Sep;21 Suppl B:19B-25B.

PMID:
16239983
12.

Management of atrial fibrillation in the elderly.

Aronow WS.

Minerva Med. 2009 Feb;100(1):3-24. Epub 2009 Jan 30. Review.

PMID:
19182738
13.

Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.

Li D, Sun H, Levesque P.

Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):64-75. Review.

PMID:
19149545
14.

Medical management of atrial fibrillation: state of the art.

Camm J.

J Cardiovasc Electrophysiol. 2006 Sep;17 Suppl 2:S2-6. Review.

PMID:
16939435
15.

New drugs for atrial fibrillation.

Hammwöhner M, Smid J, Lendeckel U, Goette A.

J Interv Card Electrophysiol. 2008 Oct;23(1):15-21. doi: 10.1007/s10840-008-9278-2. Epub 2008 Jun 6. Review.

PMID:
18535890
16.

Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.

Aronow WS.

Cardiol Rev. 2008 Jul-Aug;16(4):181-8. doi: 10.1097/CRD.0b013e31816de1e3. Review.

PMID:
18562808
17.

Safety considerations in the pharmacological management of atrial fibrillation.

Camm AJ.

Int J Cardiol. 2008 Jul 21;127(3):299-306. doi: 10.1016/j.ijcard.2007.11.006. Epub 2008 Jan 8. Review.

PMID:
18191470
18.

Prophylaxis and management of postoperative atrial fibrillation.

Onalan O, Lashevsky I, Crystal E.

Curr Cardiol Rep. 2005 Sep;7(5):382-90. Review.

PMID:
16105495
19.

Drug therapy for atrial fibrillation.

Musco S, Conway EL, Kowey PR.

Med Clin North Am. 2008 Jan;92(1):121-41, xi. Review.

PMID:
18061001
20.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

Supplemental Content

Support Center